# Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension

> **NCT07294794** · NA · NOT_YET_RECRUITING · sponsor: **University of Birmingham** · enrollment: 400 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **OTHER:** Standard of Care (SOC)
- **OTHER:** Pharmacometabolomic approach

## Key facts

- **NCT ID:** NCT07294794
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-19
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07294794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07294794, "Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07294794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*